Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores

<p>Abstract</p> <p>Background</p> <p>Chronic Kidney Disease is a major cause of morbidity and interventions now exist which can reduce risk. We sought to develop and validate two new risk algorithms (the QKidney<sup>® </sup>Scores) for estimating (a) the ind...

Full description

Bibliographic Details
Main Authors: Coupland Carol, Hippisley-Cox Julia
Format: Article
Language:English
Published: BMC 2010-06-01
Series:BMC Family Practice
Online Access:http://www.biomedcentral.com/1471-2296/11/49
_version_ 1811329800108769280
author Coupland Carol
Hippisley-Cox Julia
author_facet Coupland Carol
Hippisley-Cox Julia
author_sort Coupland Carol
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Chronic Kidney Disease is a major cause of morbidity and interventions now exist which can reduce risk. We sought to develop and validate two new risk algorithms (the QKidney<sup>® </sup>Scores) for estimating (a) the individual 5 year risk of moderate-severe CKD and (b) the individual 5 year risk of developing End Stage Kidney Failure in a primary care population.</p> <p>Methods</p> <p>We conducted a prospective open cohort study using data from 368 QResearch<sup>® </sup>general practices to develop the scores. We validated the scores using two separate sets of practices - 188 separate QResearch<sup>® </sup>practices and 364 practices contributing to the THIN database.</p> <p>We studied 775,091 women and 799,658 men aged 35-74 years in the QResearch<sup>® </sup>derivation cohort, who contributed 4,068,643 and 4,121,926 person-years of observation respectively.</p> <p>We had two main outcomes (a) moderate-severe CKD (defined as the first evidence of CKD based on the earliest of any of the following: kidney transplant; kidney dialysis; diagnosis of nephropathy; persistent proteinuria; or glomerular filtration rate of < 45 mL/min) and (b) End Stage Kidney Failure.</p> <p>We derived separate risk equations for men and women. We calculated measures of calibration and discrimination using the two separate validation cohorts.</p> <p>Results</p> <p>Our final model for moderate-severe CKD included: age, ethnicity, deprivation, smoking, BMI, systolic blood pressure, diabetes, rheumatoid arthritis, cardiovascular disease, treated hypertension, congestive cardiac failure; peripheral vascular disease, NSAID use and family history of kidney disease. In addition, it included SLE and kidney stones in women. The final model for End Stage Kidney Failure was similar except it did not include NSAID use.</p> <p>Each risk prediction algorithms performed well across all measures in both validation cohorts. For the THIN cohort, the model to predict moderate-severe CKD explained 56.38% of the total variation in women and 57.49% for men. The D statistic values were high with values of 2.33 for women and 2.38 for men. The ROC statistic was 0.875 for women and 0.876 for men.</p> <p>Conclusions</p> <p>These new algorithms have the potential to identify high risk patients who might benefit from more detailed assessment, closer monitoring or interventions to reduce their risk.</p>
first_indexed 2024-04-13T15:50:15Z
format Article
id doaj.art-e237986499614bc19226f2da9a4412af
institution Directory Open Access Journal
issn 1471-2296
language English
last_indexed 2024-04-13T15:50:15Z
publishDate 2010-06-01
publisher BMC
record_format Article
series BMC Family Practice
spelling doaj.art-e237986499614bc19226f2da9a4412af2022-12-22T02:40:52ZengBMCBMC Family Practice1471-22962010-06-011114910.1186/1471-2296-11-49Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>ScoresCoupland CarolHippisley-Cox Julia<p>Abstract</p> <p>Background</p> <p>Chronic Kidney Disease is a major cause of morbidity and interventions now exist which can reduce risk. We sought to develop and validate two new risk algorithms (the QKidney<sup>® </sup>Scores) for estimating (a) the individual 5 year risk of moderate-severe CKD and (b) the individual 5 year risk of developing End Stage Kidney Failure in a primary care population.</p> <p>Methods</p> <p>We conducted a prospective open cohort study using data from 368 QResearch<sup>® </sup>general practices to develop the scores. We validated the scores using two separate sets of practices - 188 separate QResearch<sup>® </sup>practices and 364 practices contributing to the THIN database.</p> <p>We studied 775,091 women and 799,658 men aged 35-74 years in the QResearch<sup>® </sup>derivation cohort, who contributed 4,068,643 and 4,121,926 person-years of observation respectively.</p> <p>We had two main outcomes (a) moderate-severe CKD (defined as the first evidence of CKD based on the earliest of any of the following: kidney transplant; kidney dialysis; diagnosis of nephropathy; persistent proteinuria; or glomerular filtration rate of < 45 mL/min) and (b) End Stage Kidney Failure.</p> <p>We derived separate risk equations for men and women. We calculated measures of calibration and discrimination using the two separate validation cohorts.</p> <p>Results</p> <p>Our final model for moderate-severe CKD included: age, ethnicity, deprivation, smoking, BMI, systolic blood pressure, diabetes, rheumatoid arthritis, cardiovascular disease, treated hypertension, congestive cardiac failure; peripheral vascular disease, NSAID use and family history of kidney disease. In addition, it included SLE and kidney stones in women. The final model for End Stage Kidney Failure was similar except it did not include NSAID use.</p> <p>Each risk prediction algorithms performed well across all measures in both validation cohorts. For the THIN cohort, the model to predict moderate-severe CKD explained 56.38% of the total variation in women and 57.49% for men. The D statistic values were high with values of 2.33 for women and 2.38 for men. The ROC statistic was 0.875 for women and 0.876 for men.</p> <p>Conclusions</p> <p>These new algorithms have the potential to identify high risk patients who might benefit from more detailed assessment, closer monitoring or interventions to reduce their risk.</p>http://www.biomedcentral.com/1471-2296/11/49
spellingShingle Coupland Carol
Hippisley-Cox Julia
Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
BMC Family Practice
title Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
title_full Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
title_fullStr Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
title_full_unstemmed Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
title_short Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
title_sort predicting the risk of chronic kidney disease in men and women in england and wales prospective derivation and external validation of the qkidney sup r sup scores
url http://www.biomedcentral.com/1471-2296/11/49
work_keys_str_mv AT couplandcarol predictingtheriskofchronickidneydiseaseinmenandwomeninenglandandwalesprospectivederivationandexternalvalidationoftheqkidneysupsupscores
AT hippisleycoxjulia predictingtheriskofchronickidneydiseaseinmenandwomeninenglandandwalesprospectivederivationandexternalvalidationoftheqkidneysupsupscores